Clinical practice guidelines for the care and treatment of breast cancer: Adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update)

CMAJ. Canadian Medical Association Journal

Volumn 164, Issue 2, 2001, Pages 213-

  Levine, M ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CLINICAL PRACTICE; HUMAN; NOTE; PATIENT CARE; PRACTICE GUIDELINE;

EID: 0035936497     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (4)

1. Treatment of Breast Cancer Clinical practice guidelines for the care and treatment of breast cancer: 7. Adjuvant systemic therapy for women with node-negative breast cancer
2. Polychemotherapy for early breast cancer: An overview of the randomised trials
3. Tamoxifen for early breast cancer: An overview of the randomised trials
4. Chemotherapy with or without tamoxifen for patients with ER negative breast cancer and negative nodes: Results from NSABP B23